2,639
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa

, , &
Pages 998-1009 | Received 22 Apr 2016, Accepted 19 Jan 2017, Published online: 07 Feb 2017
 

Abstract

Context: Visceral leishmaniasis is a protozoan disease caused by Leishmania donovani parasite. The genus Sterculia (Malvaceae) possesses ethnobotanical potential against this protozoan infection.

Objective: Determining the potential role of methanol bark extracts from Sterculia villosa Roxb (SVE) and its phytoconstituents against Leishmania donovani promastigotes.

Materials and methods: SVE was analysed by TLC, UV–Vis, IR spectroscopy and biochemical assays. Antileishmanial potential of SVE (0.5–130 μg/mL for 72 h) was characterized by MTT assay. Fluorescent microscopy was performed to validate the IC50 dose. To determine the effect of SVE on promastigotes, reactive oxygen species (ROS) and superoxide generation, lipid peroxidation and DNA fragmentation assays were performed. Molecular aggregation of compounds was determined by atomic force microscopy (AFM). Extent of cytotoxicity of SVE at IC50 dose was determined against RAW 264.7 macrophages, peritoneal macrophages and murine RBCs. In vivo cytotoxicity of SVE was evaluated in BALB/c mice.

Result: SVE exhibited reverse dose dependent antileishmanial activity when 130–0 μg/mL doses were tested against promastigotes. The IC50 and IC70 values were found to be 17.5 and 10 μg/mL, respectively. SVE at IC50 dose demonstrated elevated level of ROS, superoxide, lipid peroxidation and DNA fragmentation against promastigotes with no cytotoxicity. AFM analysis suggested increasing size of molecular aggregation (31.3 nm < 35.2 nm < 2.93 μm) with increase in concentration (10 μg < 17.5 μg < 130 μg).

Discussion and conclusions: The study elucidates the antileishmanial potential of SVE against Leishmania donovani promastigotes by exerting oxidative stress and DNA damage. In sum, SVE can be explored as an immunotherapeutic candidate against leishmaniasis and other infectious diseases.

Acknowledgements

Authors would like to acknowledge State Biotech Hub, Tripura University for extending their instrumental facility to complete the work. Authors are very much thankful to Pintu Debnath and Dr. Syed Arshad Hussain, Department of Physics, Tripura University for their instrumental support for AFM and Fluorescence Spectrophotometer. Authors are also thankful to Akshay Daware, Priya Gupta, Maumita Saha and Shukdev Acharjee of Dept. of Molecular Biology and Bioinformatics, Tripura University for their kind support.

Disclosure statement

The authors report no declarations of interest. The authors alone are responsible for the content and writing of this article.

Additional information

Funding

This research is supported by University Grants Commission (UGC), Govt. of India, through Rajiv Gandhi National Fellowship [Award No. F1-17.1/2016-17/RGNF-2015-17-SC-TRI-488] and Indian Council of Medical Research Project [Sanction No. 55/5/2012-(Pt. iv)-BMS], Govt. of India.